|
Nasdaq Oracle Corp., up $1.19 at $29.54 Orexigen Therapeutics Inc., up 72 cents at $2.19 NuVasive Inc., down $2.56 at $18.65
The software company reported quarterly results that slightly exceeded what Wall Street had been expecting.
The biopharmaceutical company said it received federal approval to revive its previously abandoned weight loss drug Contrave.
A federal jury ruled that the medical device maker must pay rival Medtronic $101 million in damages for infringing on its patents.
Copyright 2011 The Associated
Press. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
News | Sports | Business | Rural Review | Teaching & Learning | Home and Family | Tourism | Obituaries
Community |
Perspectives
|
Law & Courts |
Leisure Time
|
Spiritual Life |
Health & Fitness |
Teen Scene
Calendar
|
Letters to the Editor